Status:
COMPLETED
Skeletal Muscle Wasting in SARS-CoV-2
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
Conditions:
Cachexia
Muscle Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The SARS-CoV-2 pandemic causes a major burden on patient and staff admitted/working on the intensive care unit (ICU). Short, and especially long admission on the ICU causes major reductions in skeleta...
Eligibility Criteria
Inclusion
- Age \>18 years
- SARS-CoV-2 infection
- Expected stay to ICU of \> 7 days
Exclusion
- Spinal cord injury
- Chronic use of corticosteroids before hospital admission
Key Trial Info
Start Date :
January 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04698798
Start Date
January 2 2021
End Date
April 3 2021
Last Update
July 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Ziekenhuis
Hasselt, Belgium, 3500